![]() |
市場調查報告書
商品編碼
1933374
全球採血針市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測(2026-2034)Lancet Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受糖尿病盛行率上升和常規診斷檢測需求增加的推動,全球採血針市場在2025年保持穩定成長。根據本報告,全球採血針市場預計在2025年達到23.1億美元,並從2026年的25.4億美元成長到2034年的57.4億美元,預測期內複合年增長率(CAGR)為10.72%。北美地區在2025年佔市場主導地位,市佔率達34.98%,主要得益於先進血糖監測設備的廣泛應用和有利的報銷政策。
採血針是一種小型、鋒利的醫療器械,主要用於採集毛細血管血樣,以進行血糖測量、血紅蛋白檢測和膽固醇監測。這些器械廣泛應用於醫院、診斷實驗室和家庭醫療保健機構。人們對預防針刺傷的意識不斷提高,以及安全型採血針的日益普及,都顯著推動了市場成長。
市場動態
市場驅動因素
糖尿病和慢性疾病盛行率的上升是全球採血針市場的主要驅動因素。糖尿病患者廣泛使用採血針進行日常血糖監測。根據健康指標與評估研究所(IHME,2023年6月)的數據,全球有超過5億人患有糖尿病。此外,家庭診斷解決方案的日益普及以及對微創採血技術的偏好,也推動了對先進安全型採血針的需求。
市場限制因子
安全採血針的價格敏感性預計將抑制市場成長,尤其是在發展中地區。安全採血針比傳統採血針更昂貴,這限制了其在註重成本的醫療保健系統中的普及。根據英國國家醫療服務體系 (NHS) 2020 年 10 月發布的數據,安全採血針每 100 支的成本約為 4.87 至 5.06 美元,而標準採血針每 100 支的成本約為 2.37 至 4.22 美元,這阻礙了先進產品的廣泛應用。
市場機會
對家庭醫療監測需求的成長創造了豐厚的成長機會。隨著越來越多的患者在家中管理糖尿病等慢性疾病,對易於使用且安全的採血設備的需求也不斷增長。 根據發表在 "印度醫學科學雜誌" (2023年12月刊)上的一項研究,35%的患者在家使用血糖儀進行自我監測,這支撐了採血針消費量的增長。
採血針市場趨勢
技術創新和永續產品設計正成為關鍵趨勢。製造商正在開發採用彈簧裝置和人體工學設計的超細規格(21G-30G)採血針,以最大限度地減少疼痛並提高患者舒適度。此外,更嚴格的安全銳器法規以及對使用減少塑膠和可生物降解材料的環保設計的日益重視,也影響產品開發。
依類型
市場依類型分為標準採血針、安全採血針及特殊採血針。 預計到 2026 年,安全採血針細分市場將以 51.55% 的市場佔有率領先,這主要得益於需要頻繁檢測的糖尿病患者對採血針的接受度不斷提高。
依切口類型劃分
市場分為針式採血針和刀片式採血針。預計到 2026 年,針式採血針細分市場將以 93.65% 的市場佔有率領先,這主要得益於其疼痛減輕、易於使用和卓越的安全性。
依年齡組別劃分
預計到 2025 年和 2026 年,成年人群體將分別以 72.8% 和 72.92% 的市場佔有率主導市場,這主要得益於糖尿病和膽固醇檢測的高普及率。 預計兒科市場將以 10.1% 的複合年增長率成長。
依規格尺寸劃分
23G-28G 規格的針頭在 2025 年和 2026 年分別佔 73.3% 和 73.35% 的市場佔有率,這主要得益於其在舒適度和血液流動效率方面的最佳平衡。
依應用程式劃分
血糖監測在 2025 年佔 56.3% 的市場佔有率,這主要得益於全球糖尿病患者人數的不斷增長。 預計血紅素檢測的複合年增長率將達到 10.8%。
依通路劃分
零售藥局將佔市場主導地位,到 2025 年將保持 51.9% 的市場佔有率,這主要得益於其便利性和全面的糖尿病護理服務。
北美地區在健保報銷政策和先進醫療基礎設施的支持下,將引領市場,預計 2025 年市場規模將達到 8.1 億美元,2026 年將達到 8.8 億美元。歐洲市場預計 2025 年將達到 7.8 億美元,而亞太地區則佔 6.2 億美元。 預計到 2025 年,拉丁美洲和中東及非洲地區的市場規模將分別達到 7,000 萬美元和 2,000 萬美元。
The global lancet market recorded steady growth in 2025, supported by the rising prevalence of diabetes and increasing demand for routine diagnostic testing. According to the report, the global lancet market size was valued at USD 2.31 billion in 2025 and is projected to grow from USD 2.54 billion in 2026 to USD 5.74 billion by 2034, exhibiting a CAGR of 10.72% during the forecast period. North America dominated the market with a 34.98% share in 2025, driven by strong adoption of advanced blood glucose monitoring devices and favorable reimbursement policies.
Lancets are small, sharp medical devices used for capillary blood sampling, primarily for blood glucose testing, hemoglobin testing, and cholesterol monitoring. These devices are widely used in hospitals, diagnostic laboratories, and home-care settings. Growing awareness regarding needle-stick injury prevention and the rising adoption of safety-engineered lancets are significantly contributing to market expansion.
Market Dynamics
Market Drivers
The rising prevalence of diabetes and chronic diseases is a key driver of the global lancet market. Lancets are extensively used by diabetic patients for daily blood glucose monitoring. According to the Institute for Health Metrics and Evaluation (June 2023), over half a billion people worldwide are living with diabetes. Additionally, increasing adoption of home-based diagnostic solutions and the preference for minimally invasive blood sampling techniques are driving demand for advanced safety lancets.
Market Restraints
The cost sensitivity of safety lancets is expected to restrain market growth, particularly in developing regions. Safety lancets are more expensive than traditional lancets, limiting their adoption in cost-conscious healthcare systems. NHS data published in October 2020 showed that safety lancets cost approximately USD 4.87-5.06 per 100 units, compared to USD 2.37-4.22 per 100 units for standard lancets, discouraging widespread adoption of advanced products.
Market Opportunities
The increasing need for home healthcare monitoring is creating lucrative growth opportunities. As more patients manage chronic conditions such as diabetes at home, demand for easy-to-use and safe blood sampling devices is rising. A study published in the Indian Journal of Medical Specialties (December 2023) indicated that 35% of patients used glucometers for self-monitoring at home, supporting increased lancet consumption.
Lancet Market Trends
Technological advancements and sustainable product designs are emerging as key trends. Manufacturers are developing ultra-fine gauge lancets (21G-30G) with spring-loaded and ergonomic mechanisms to minimize pain and improve patient comfort. Additionally, regulatory emphasis on safety-engineered sharps and growing focus on environmentally friendly designs using reduced plastic and biodegradable materials are influencing product development.
By Type
Based on type, the market is segmented into standard lancets, safety lancets, and specialty lancets. The safety lancets segment is projected to dominate with a 51.55% share in 2026, driven by increasing adoption among diabetic patients requiring frequent testing.
By Incision Type
The market is categorized into needle and blade lancets. The needle segment is projected to lead with a 93.65% share in 2026, owing to reduced pain, ease of use, and superior safety features.
By Age Group
Adults dominated the market with a 72.8% share in 2025 and are expected to account for 72.92% in 2026, supported by higher testing rates for diabetes and cholesterol. The pediatric segment is projected to grow at a CAGR of 10.1%.
By Gauge Size
The 23G-28G segment dominated with a 73.3% share in 2025 and 73.35% in 2026, due to optimal balance between comfort and blood flow efficiency.
By Application
Blood glucose monitoring dominated the market with a 56.3% share in 2025, supported by the increasing global diabetic population. Hemoglobin testing is expected to grow at a CAGR of 10.8%.
By Distribution Channel
Retail pharmacies dominated the market and are projected to hold a 51.9% share in 2025, driven by accessibility and bundled diabetes care offerings.
North America led the market with USD 0.81 billion in 2025 and USD 0.88 billion in 2026, supported by reimbursement policies and advanced healthcare infrastructure. Europe reached USD 0.78 billion in 2025, while Asia Pacific accounted for USD 0.62 billion. Latin America and the Middle East & Africa recorded USD 0.07 billion and USD 0.02 billion, respectively, in 2025.
Competitive Landscape
The global lancet market is highly fragmented, with key players such as BD, HTL-STREFA, Abbott, Cardinal Health, and Terumo Medical Corporation holding significant market presence. These companies focus on product innovation, capacity expansion, and geographic growth. In January 2025, BD announced investments in U.S. manufacturing facilities to increase production capacity for lancets and other critical medical devices.
Conclusion
The global lancet market was valued at USD 2.31 billion in 2025 and is expected to grow from USD 2.54 billion in 2026 to USD 5.74 billion by 2034, supported by rising diabetes prevalence, growing home-based diagnostics, and increasing adoption of safety lancets. North America maintained market dominance, while Europe and Asia Pacific exhibited strong growth potential. Despite challenges related to cost sensitivity and limited healthcare spending in developing regions, technological advancements, safety-focused regulations, and expanding self-monitoring practices are expected to sustain market growth through 2034.
Segmentation By Type
By Incision Type
By Age Group
By Gauge Size
By Application
By Distribution Channel
By Geography
North America (By Type, Incision Type, Age Group, Gauge Size, Application, Distribution Channel, and Country)